Lexpos News

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 3 October 2023) has been published and includes articles on: Isotretinoin (Roaccutane▼): introduction of new safety measures, including additional oversight of the initiation of treatment for patients under 18 years of age MedSafetyWeek November 2023: your Yellow Card report helps [...]

The post MHRA Drug Safety Update: October 2023 appeared first on Community Pharmacy England.

Pharmacy Press As today marks the beginning of Ask Your Pharmacist Week (October 30th to November 6th), the National Pharmacy Association (NPA) has also released survey data highlighting that more people in England are embracing community pharmacies as key healthcare settings. This polling data supports the wider efforts to promote the crucial role of pharmacies [...]

The post #AskYourPharmacistWeek: NPA data highlights public appreciation of Community Pharmacy appeared first on Community Pharmacy England.

The Sunday Times  The supply issues for ADHD medicines have intensified alongside a significant increase in patient demand. The situation presents as a growing challenge for community pharmacies that are unable to obtain stock. Additionally, GPs are also having to refer patients back to specialist clinics for dose adjustments, which is leading to delays in [...]

The post ADHD diagnoses surge amid escalating medicine supply challenges appeared first on Community Pharmacy England.

Community pharmacy owners are being asked to share their views on the coming winter and beyond, ahead of the next full Community Pharmacy England Committee meeting which will be held in November. This committee meeting comes at a critical time as the unsustainable pressures on community pharmacies continue through the autumn period, and our Committee [...]

The post Winter Pressures and the Future: Pharmacy Owner Views Sought appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Jext® 300micrograms/0.3ml (1 in 1000) solution for injection auto-injector pen are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP058 Jext® 300micrograms/0.3ml (1 in 1000) solution for injection auto-injector pen at 23.59pm on Friday 27 October 2023. After this [...]

The post Expiry of SSP058 Jext® 300micrograms/0.3ml (1 in 1000) solution for injection auto-injector pen appeared first on Community Pharmacy England.